The Rare and Atypical Diabetes Network (RADIANT) Study: Design and Early Results.
dc.contributor.author | RADIANT Study Group | |
dc.coverage.spatial | United States | |
dc.date.accessioned | 2023-05-31T14:50:57Z | |
dc.date.available | 2023-05-31T14:50:57Z | |
dc.date.issued | 2023-04-27 | |
dc.identifier.issn | 0149-5992 | |
dc.identifier.issn | 1935-5548 | |
dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pubmed/37104866 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/176788 | en |
dc.description.abstract | OBJECTIVE: The Rare and Atypical Diabetes Network (RADIANT) will perform a study of individuals and, if deemed informative, a study of their family members with uncharacterized forms of diabetes. RESEARCH DESIGN AND METHODS: The protocol includes genomic (whole-genome [WGS], RNA, and mitochondrial sequencing), phenotypic (vital signs, biometric measurements, questionnaires, and photography), metabolomics, and metabolic assessments. RESULTS: Among 122 with WGS results of 878 enrolled individuals, a likely pathogenic variant in a known diabetes monogenic gene was found in 3 (2.5%), and six new monogenic variants have been identified in the SMAD5, PTPMT1, INS, NFKB1, IGF1R, and PAX6 genes. Frequent phenotypic clusters are lean type 2 diabetes, autoantibody-negative and insulin-deficient diabetes, lipodystrophic diabetes, and new forms of possible monogenic or oligogenic diabetes. CONCLUSIONS: The analyses will lead to improved means of atypical diabetes identification. Genetic sequencing can identify new variants, and metabolomics and transcriptomics analysis can identify novel mechanisms and biomarkers for atypical disease. | |
dc.format.medium | Print-Electronic | |
dc.language | eng | |
dc.publisher | American Diabetes Association | |
dc.subject | RADIANT Study Group | |
dc.title | The Rare and Atypical Diabetes Network (RADIANT) Study: Design and Early Results. | |
dc.type | Article | |
dc.identifier.pmid | 37104866 | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/176788/2/dc222440.pdf | |
dc.identifier.doi | 10.2337/dc22-2440 | |
dc.identifier.doi | https://dx.doi.org/10.7302/7637 | |
dc.identifier.source | Diabetes Care | |
dc.description.version | Published online | |
dc.date.updated | 2023-05-31T14:50:51Z | |
dc.description.filedescription | Description of dc222440.pdf : Published version | |
dc.identifier.startpage | dc222440 | |
dc.identifier.name-orcid | RADIANT Study Group | |
dc.working.doi | 10.7302/7637 | en |
dc.owningcollname | Internal Medicine, Department of |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.